SciGenom

Kochi, India Founded: 2009 • Age: 17 yrs
Provider of genome sequencing and bioinformatics services life science and healthcare sector
Annual revenue $688,869 Latest available
Total funding $364,032 2 rounds
Employees 12 Tracked headcount
Investors 3 Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About SciGenom

SciGenom is a company based in Kochi (India) founded in 2009 by Sam Santhosh. SciGenom has raised $364.03 thousand across 2 funding rounds from investors including Department of Biotechnology, Shreedharn Nair and Jlds Research AND Consultancy. The company has 12 employees as of March 31, 2024. SciGenom operates in a competitive market with competitors including Novogene Corporation, Rejuvenate Bio, Source BioScience, Strateos and Beikang Medical, among others.

  • Headquarter Kochi, India
  • Employees 12 as on 31 Mar, 2024
  • Founders Sam Santhosh
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
    $688.87 K (USD)
    2
    as on Mar 31, 2024
  • Net Profit
    $65.84 K (USD)
    111
    as on Mar 31, 2024
  • EBITDA
    $136.49 K (USD)
    127
    as on Mar 31, 2024
  • Total Equity Funding
    $364.03 K (USD)

    in 2 rounds

  • Latest Funding Round
  • Investors
  • Employee Count
    12

    as on Mar 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of SciGenom

SciGenom has successfully raised a total of $364.03K across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round
  • First Round

    (29 Mar 2012)

  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2015 Amount Grant - SciGenom Valuation

investors

Mar, 2012 Amount Seed - SciGenom Valuation Jlds Research AND Consultancy

Investors in SciGenom

SciGenom has secured backing from 3 investors, including institutional and angel investors. Prominent investors backing the company include Department of Biotechnology, Shreedharn Nair and Jlds Research AND Consultancy.

All
Institutional
Angel
Investor Description Founded Year Domain Location
Biotechnology research, guidelines, and funding by the Government of India.
Founded Year Domain Location
-
Founded Year Domain Location

Shreedharn Nair

-
Founded Year Domain Location

Investments & Acquisitions by SciGenom

Investments

Financial Statements - SciGenom

Scigenom Comparisons

+
Add Comparison
Available on Premium

Competitors of SciGenom

SciGenom operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novogene Corporation, Rejuvenate Bio, Source BioScience, Strateos and Beikang Medical, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Genomic services and solutions with NGS expertise are provided.
domain founded_year HQ Location
Gene-editing platform and anti-aging therapy for dogs are developed.
domain founded_year HQ Location
Multiple genomic services are provided for analysis and diagnostics.
domain founded_year HQ Location
Provider of cloud based platform provides data driven information for biotech research
domain founded_year HQ Location
NGS-based diagnostic solutions for neonatal screening are developed.
domain founded_year HQ Location
Next-generation sequencing and genomics services are provided globally.

Latest news on Scigenom

Frequently Asked Questions about SciGenom

SciGenom was founded in 2009 and raised its 1st funding round 3 years after it was founded.

SciGenom is headquartered in Kochi, India. It is registered at Kochi, Kerala, India.

Sam Santhosh is the current CEO of SciGenom. They have also founded this company.

SciGenom is a funded company, having raised a total of $364.03K across 2 funding rounds to date. The company's 1st funding round was a Seed of $364.03K, raised on Mar 29, 2012.

As of Mar 31, 2024, the latest employee count at SciGenom is 12.

Annual revenue of SciGenom is $688.87K as on Mar 31, 2024.

SciGenom was founded in 2009 and is based in Kochi, India. Genome sequencing services, including next-generation and Sanger methods, are offered alongside bioinformatics tools for data analysis and laboratory information management. Additional operations encompass custom oligonucleotide synthesis, microbial identification, and cloning. Grants from DBT under SBIRI and BIPP have supported development of single-tube multigene oncodiagnostic tests compatible with NGS platforms, serving the life science and healthcare sectors.

SciGenom's top competitors include Novogene Corporation, Source BioScience and Genewiz.

SciGenom has 3 investors. Key investors include Department of Biotechnology, Shreedharn Nair, and Jlds Research AND Consultancy.

The valuation of SciGenom is $379.92K as of Mar 2012.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available